Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price shot up 14.5% during mid-day trading on Friday . The company traded as high as GBX 249 ($3.37) and last traded at GBX 248 ($3.35). 37,369,863 shares traded hands during trading, an increase of 2,206% from the average session volume of 1,620,847 shares. The stock had previously closed at GBX 216.50 ($2.93).
Wall Street Analyst Weigh In
SPI has been the subject of a number of analyst reports. JPMorgan Chase & Co. dropped their price objective on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Berenberg Bank reaffirmed a "buy" rating and issued a GBX 280 target price on shares of Spire Healthcare Group in a research report on Thursday, July 31st. Three analysts have rated the stock with a Buy rating, According to MarketBeat, Spire Healthcare Group currently has a consensus rating of "Buy" and an average target price of GBX 294.33.
View Our Latest Research Report on Spire Healthcare Group
Spire Healthcare Group Trading Up 3.2%
The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 62.25. The business has a fifty day simple moving average of GBX 218.99 and a 200 day simple moving average of GBX 203.96. The company has a market cap of £978.32 million, a price-to-earnings ratio of 5,285.65, a P/E/G ratio of 1.06 and a beta of 0.96.
Spire Healthcare Group (LON:SPI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, equities analysts anticipate that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Further Reading
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.